| Mary Kathleen D Kelley, RN, LPC | |
|
810 Bestgate Rd Ste 325, Annapolis, MD 21401-3648 | |
| (571) 344-4224 | |
| Not Available |
| Full Name | Mary Kathleen D Kelley |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 810 Bestgate Rd Ste 325, Annapolis, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235774696 | NPI | - | NPPES |
| Entity Name | Commonwealth Counseling Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851345805 PECOS PAC ID: 0941288583 Enrollment ID: O20210302002411 |
News Archive
Tuberculosis is one of the world's most vexing public health problems. About 1.5 million people died from this bacterial lung infection in 2018, and the World Health Organization estimates that one-quarter of the world's population - some 2 billion people, mostly in developing countries - are infected with the bacteria that causes TB.
George Brown College is collaborating with MEMOTEXT, a patient adherence and medication compliance company, to develop an inference-based telephone/short message service (SMS) based communications program for an overseas health stakeholder-based research project.
In a recent study conducted at the Indian Institute of Science Education and Research, India, a team of scientists screened specific genes of SARS-CoV-2 to identify factors that may contribute to viral infectivity.
The Institute of Medicine held a forum this week in which advocates could offer input regarding what types of medical services should be included in the insurance plans that are offered on the exchanges created by the new health law.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Kathleen D Kelley, RN, LPC 810 Bestgate Rd Ste 325, Annapolis, MD 21401-4291 Ph: (703) 831-8300 | Mary Kathleen D Kelley, RN, LPC 810 Bestgate Rd Ste 325, Annapolis, MD 21401-3648 Ph: (571) 344-4224 |
News Archive
Tuberculosis is one of the world's most vexing public health problems. About 1.5 million people died from this bacterial lung infection in 2018, and the World Health Organization estimates that one-quarter of the world's population - some 2 billion people, mostly in developing countries - are infected with the bacteria that causes TB.
George Brown College is collaborating with MEMOTEXT, a patient adherence and medication compliance company, to develop an inference-based telephone/short message service (SMS) based communications program for an overseas health stakeholder-based research project.
In a recent study conducted at the Indian Institute of Science Education and Research, India, a team of scientists screened specific genes of SARS-CoV-2 to identify factors that may contribute to viral infectivity.
The Institute of Medicine held a forum this week in which advocates could offer input regarding what types of medical services should be included in the insurance plans that are offered on the exchanges created by the new health law.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
› Verified 5 days ago
Jada Rogers, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 185 Admiral Cochrane Dr Ste 225, Annapolis, MD 21401 Phone: 443-440-5782 | |
Mrs. Shirley L Gordon, CAC, CMHT, CPRS Counselor Medicare: Not Enrolled in Medicare Practice Location: 92 W Washington St, Annapolis, MD 21401 Phone: 443-949-9545 Fax: 240-366-0055 | |
Ms. Marcia S Harrison, MMH, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1316 Forest Dr, Annapolis, MD 21403 Phone: 410-266-6884 Fax: 410-224-3423 | |
Mrs. Amy T. Masser, Counselor Medicare: Not Enrolled in Medicare Practice Location: 108 Old Solomons Island Rd, U7, Annapolis, MD 21401 Phone: 410-266-8345 Fax: 410-266-6278 | |
Ms. Nancy L Mccamish, LCPAT Counselor Medicare: Not Enrolled in Medicare Practice Location: 108 Old Solomons Island Rd, U7, Annapolis, MD 21401 Phone: 410-266-8345 Fax: 410-266-6278 | |
Dr. John Wirth, MS, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 102 Old Solomons Island Rd Ste 202, Annapolis, MD 21401 Phone: 410-266-3058 | |
Sarah Lynn Hern, LCSW-C Counselor Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1272 Fax: 443-481-1267 |